Special Issue "State-of-the-Art Endocrinology and Metabolism Research in Poland (Volume II)"

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".

Deadline for manuscript submissions: 31 January 2024 | Viewed by 1314

Special Issue Editor

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrzeze L. Pasteura 4, 50-367 Wroclaw, Poland
Interests: Endocrinology; Diabetes;
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This special issue “State-of-the-Art Endocrinology and Metabolism Research in Poland” aims to publish papers from Poland on all aspects of endocrinology and metabolism Research. Topics include but are not limited to the following:

  • Endocrine systems and endocrine diseases;
  • Developmental endocrinology;
  • Genetic endocrinology;
  • Diabetes;
  • Obesity;
  • Osteoporosis;
  • Hyperthyroidism;
  • Metabolic diseases;
  • Hormonal diseases (thyroid diseases, parathyroid diseases, hypothalamic diseases, pituitary diseases, adrenal diseases, pancreatic diseases, gonadal diseases);
  • Neuroendocrinology and neuroendocrine control of endocrine axes;
  • Endocrine-related tumor and cancer;
  • Hormone receptors, hormone action and regulation.

We warmly welcome original research article and review articles relating to this topic.

Prof. Dr. Marek Bolanowski
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • endocrinology
  • diabetes
  • obesity
  • osteoporosis
  • hyperthyroidism
  • metabolism
  • genetic

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 285 KiB  
Article
Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study
Biomedicines 2023, 11(4), 1211; https://doi.org/10.3390/biomedicines11041211 - 19 Apr 2023
Viewed by 1005
Abstract
Acromegaly is a rare endocrine disorder caused by somatotroph pituitary adenoma. Besides its typical symptoms, it contributes to the development of cardiovascular, metabolic, and bone comorbidities. H19 RNA is a long non-coding RNA and it is suspected to be involved in tumorigenesis, cancer [...] Read more.
Acromegaly is a rare endocrine disorder caused by somatotroph pituitary adenoma. Besides its typical symptoms, it contributes to the development of cardiovascular, metabolic, and bone comorbidities. H19 RNA is a long non-coding RNA and it is suspected to be involved in tumorigenesis, cancer progression, and metastasis. H19 RNA is a novel biomarker for the diagnosis and monitoring of neoplasms. Moreover, there might be an association between H19 and cardiovascular and metabolic diseases. We enrolled 32 acromegaly patients and 25 controls. We investigated whether whole blood H19 RNA expression is associated with the diagnosis of acromegaly. Correlations between H19 and tumour dimension, invasiveness, and biochemical and hormonal parameters were evaluated. We analysed the coincidence of acromegaly comorbidities with H19 RNA expression. In the results, we did not observe a statistically significant difference in H19 RNA expression between acromegaly patients and the controls. There were no correlations between H19 and the adenoma size and infiltration and patients’ biochemical and hormonal statuses. In the acromegaly group, hypertension, goitre, and cholelithiasis were observed more frequently. The diagnosis of acromegaly was a factor contributing to the occurrence of dyslipidaemia, goitre, and cholelithiasis. We found an association between H19 and cholelithiasis in acromegaly patients. To conclude, H19 RNA expression is not a relevant marker for diagnosis and monitoring of acromegaly patients. There is a higher risk of hypertension, goitre, and cholelithiasis related to acromegaly. Cholelithiasis is associated with a higher H19 RNA expression. Full article
Back to TopTop